Cargando…
Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus
Mammalian target of rapamycin inhibitors (mTORi) are used to treat a variety of malignancies and have an established role in organ transplantation. Interstitial lung disease (ILD) is one of the complications of mTORi and is believed to be a class effect. More cases of ILD have been reported with sir...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287142/ https://www.ncbi.nlm.nih.gov/pubmed/32551222 http://dx.doi.org/10.1016/j.rmcr.2020.101109 |